Macaulay VM, Lord S, Hussain S, Maroto JP, et al. A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer. Br J Cancer 2023 Aug 3. doi: 10.1038/s41416-023-02380.
PMID: 37537253